Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Acute disseminated encephalomyelitis (ADEM) following a H3N3 parainfluenza virus infection in a pregnant asthmatic woman with respiratory failure.
[Uveitis in multiple sclerosis : Overview and perspectives.]
Retinal thickness in pediatric multiple sclerosis.
Betaferon efficiency indicators in the treatment of relapsing remitting form of multiple sclerosis.
ADEM Following Malaria.
Emerging Subspecialties in Neurology: Palliative care.
Treatment Effects Maintained Over Five Years in Majority of Patients with Relapsing Remitting Multiple Sclerosis who Received Genzyme’s Lemtrada® (alemtuzumab) in Clinical Trials
A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese.
Multiple sclerosis: from molecules to treatment.
Vitamin D and multiple sclerosis.
Short-term evolution of spinal cord damage in multiple sclerosis: a diffusion tensor MRI study.
Effect of acetazolamide for long-lasting paroxysmal dystonia in a patient with multiple sclerosis: a case report and review of literature.
A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.
Changes in Gross Grasp Strength and Fine Motor Skills in Adolescents with Pediatric Multiple Sclerosis.
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders.
Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis.
Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis.
Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia.
Assessment of system dysfunction in the brain through MRI-based connectomics.
Quality of life reporting in multiple sclerosis clinical trials: enough quality?
New extension study data with Novartis drug Gilenya® shows patients successfully treated for up to 7 years in relapsing MS
A comparative analysis of Patient-Reported Expanded Disability Status Scale tools.
Internet-delivered lifestyle physical activity intervention improves body composition in multiple sclerosis: Preliminary evidence from a randomized controlled trial.
Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations.
Confounding underlies the apparent 'month of birth' effect in multiple sclerosis.

Pages